David S. Wagner

1.6k total citations
32 papers, 1.3k citations indexed

About

David S. Wagner is a scholar working on Spectroscopy, Molecular Biology and Infectious Diseases. According to data from OpenAlex, David S. Wagner has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Spectroscopy, 14 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in David S. Wagner's work include Mass Spectrometry Techniques and Applications (15 papers), Analytical Chemistry and Chromatography (11 papers) and Advanced Proteomics Techniques and Applications (6 papers). David S. Wagner is often cited by papers focused on Mass Spectrometry Techniques and Applications (15 papers), Analytical Chemistry and Chromatography (11 papers) and Advanced Proteomics Techniques and Applications (6 papers). David S. Wagner collaborates with scholars based in United States, United Kingdom and France. David S. Wagner's co-authors include Robert J. Anderegg, Stephen Castellino, H. Mario Geysen, M. Reid Groseclose, Frank J. Schoenen, Richard W. Wagner, Bradley Brown, Gary D. Bowers, Cynthia L. Stevenson and Ronald T. Borchardt and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Chemistry and Nature Reviews Drug Discovery.

In The Last Decade

David S. Wagner

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David S. Wagner United States	18	663	607	200	130	113	32	1.3k
Steve E. Unger United States	22	478 0.7×	562 0.9×	77 0.4×	120 0.9×	30 0.3×	50	1.2k
Stephen Castellino United States	26	817 1.2×	577 1.0×	198 1.0×	582 4.5×	96 0.8×	49	2.3k
Stefania Notari Italy	15	976 1.5×	197 0.3×	248 1.2×	121 0.9×	104 0.9×	21	1.5k
Michael T. Boyne United States	21	931 1.4×	489 0.8×	66 0.3×	116 0.9×	13 0.1×	40	1.5k
Philippe Morin France	25	539 0.8×	415 0.7×	64 0.3×	54 0.4×	21 0.2×	79	1.8k
Ian M. Mutton United Kingdom	12	235 0.4×	277 0.5×	218 1.1×	139 1.1×	132 1.2×	19	753
Ashit K. Ganguly United States	24	839 1.3×	358 0.6×	92 0.5×	917 7.1×	21 0.2×	90	1.7k
M. Reid Groseclose United States	17	1.0k 1.6×	1.3k 2.1×	36 0.2×	33 0.3×	23 0.2×	24	1.7k
Sandra Steiner Switzerland	23	1.4k 2.0×	950 1.6×	48 0.2×	53 0.4×	16 0.1×	42	2.2k
Marta A. S. Perez Switzerland	14	445 0.7×	132 0.2×	61 0.3×	124 1.0×	25 0.2×	28	953

Countries citing papers authored by David S. Wagner

Since Specialization

Citations

This map shows the geographic impact of David S. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Wagner more than expected).

Fields of papers citing papers by David S. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Wagner. The network helps show where David S. Wagner may publish in the future.

Co-authorship network of co-authors of David S. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Wagner. A scholar is included among the top collaborators of David S. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Wagner. David S. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Good, Christopher J., Andrew P. Bowman, Corinna Klein, et al.. (2025). Spatial Mapping of Gangliosides and Proteins in Amyloid Beta Plaques at Cellular Resolution Using Mass Spectrometry Imaging and MALDI‐IHC. Journal of Mass Spectrometry. 60(9). e5161–e5161.

Cuyckens, Filip, Kenneth C. Cassidy, Douglas K. Spracklin, et al.. (2024). Recommendations on the Use of Multiple Labels in Human Mass Balance Studies. Drug Metabolism and Disposition. 52(3). 153–158. 2 indexed citations

Yang, Junhai, Andrew P. Bowman, Wayne R. Buck, et al.. (2024). Mass Spectrometry Imaging Distinguishes Biliary Toxicants on the Basis of Cellular Distribution. Toxicologic Pathology. 53(1). 55–64. 1 indexed citations

Freiberger, Elyse C., Michael P. Thompson, Xiaomei Zhang, et al.. (2024). Utility of Common In Vitro Systems for Predicting Circulating Metabolites. Drug Metabolism and Disposition. 52(12). 1373–1378. 3 indexed citations

Savaryn, John P., Richard L. Smith, Matthew Rosebraugh, et al.. (2024). Metabolite profiling of foslevodopa/foscarbidopa in plasma of healthy human participants by LC‐HRMS indicates no major differences compared to administration of levodopa/carbidopa intestinal gel. Pharmacology Research & Perspectives. 12(2). e1190–e1190. 3 indexed citations

Li, Wenkui, Gordon J. Dear, Jason Boer, et al.. (2023). Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group. Clinical Pharmacology & Therapeutics. 115(5). 939–953. 1 indexed citations

Young, Graeme, Douglas K. Spracklin, Mette Lund Pedersen, et al.. (2023). Non‐Labeled, Stable Labeled, or Radiolabelled Approaches for Provision of Intravenous Pharmacokinetics in Humans: A Discussion Piece. Clinical Pharmacology & Therapeutics. 115(5). 931–938. 4 indexed citations

Bowers, Gary D., Melinda J. Reese, Stephen C. Piscitelli, et al.. (2015). Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humans. Xenobiotica. 46(2). 147–162. 46 indexed citations

Song, Ivy, Julie Borland, Shuguang Chen, et al.. (2014). Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir. European Journal of Clinical Pharmacology. 70(10). 1173–1179. 30 indexed citations

10.

Faber, Catherine, Zhaohai Zhu, Stephen Castellino, et al.. (2014). Cardiolipin profiles as a potential biomarker of mitochondrial health in diet‐induced obese mice subjected to exercise, diet‐restriction and ephedrine treatment. Journal of Applied Toxicology. 34(11). 1122–1129. 11 indexed citations

11.

Bowers, Gary D., Stephen Castellino, David S. Wagner, et al.. (2012). Assessment of the Drug Interaction Risk for Remogliflozin Etabonate, a Sodium-Dependent Glucose Cotransporter-2 Inhibitor: Evidence from In Vitro, Human Mass Balance, and Ketoconazole Interaction Studies. Drug Metabolism and Disposition. 40(11). 2090–2101. 38 indexed citations

12.

Bowers, Gary D., Claire Beaumont, Mehul Dave, et al.. (2011). Evaluation of a chimeric (uPA+/+)/SCID mouse model with a humanized liver for prediction of human metabolism. Xenobiotica. 41(6). 464–475. 30 indexed citations

13.

Wagner, David S.. (2006). The Forgotten Avenue of Reform: The Role of States in Electoral College Reform and the Use of Ballot Initiatives to Effect That Change. 25(3). 575. 1 indexed citations

14.

Wagner, David S., et al.. (1998). Ratio encoding combinatorial libraries with stable isotopes and their utility in pharmaceutical research. Combinatorial Chemistry & High Throughput Screening. 1(3). 143–153. 13 indexed citations

15.

Anderegg, Robert J., David S. Wagner, Kevin Blackburn, Gregory J. Opiteck, & James W. Jorgenson. (1997). A Multidimensional Approach to Protein Characterization. Journal of Protein Chemistry. 16(5). 523–526. 14 indexed citations

16.

Geysen, H. Mario, Craig D. Wagner, Wanda M. Bodnar, et al.. (1996). Isotope or mass encoding of combinatorial libraries. Chemistry & Biology. 3(8). 679–688. 81 indexed citations

17.

Brown, Bradley, David S. Wagner, & H. Mario Geysen. (1995). A single-bead decode strategy using electrospray ionization mass spectrometry and a new photolabile linker: 3-Amino-3-(2-nitrophenyl)propionic acid. Molecular Diversity. 1(1). 4–12. 69 indexed citations

18.

Wagner, David S., et al.. (1994). Deuterium exchange of α‐helices and β‐sheets as monitored by electrospray ionization mass spectrometry. Protein Science. 3(8). 1305–1314. 53 indexed citations

19.

Wagner, David S. & Robert J. Anderegg. (1994). Conformation of Cytochrome c Studied by Deuterium Exchange-Electrospray Ionization Mass Spectrometry. Analytical Chemistry. 66(5). 706–711. 97 indexed citations

20.

Wagner, David S., et al.. (1991). Derivatization of peptides to enhance ionization effiency and control fragmentation during analysis by fast atom bombardment tandem mass spectrometry. Journal of Mass Spectrometry. 20(7). 419–425. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact